Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Some drugs may help treat both COVID-19 and radiation injury.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

JAK inhibitors offer new hope for treating severe alopecia areata.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.

Exosome therapy could be a promising new way to treat hair loss.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Alopecia areata gained more interest on social media than pattern hair loss, with TikTok showing more personal stories and YouTube offering higher quality educational content.

Digital health platforms improve treatment for male pattern hair loss.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Modifying gut bacteria with pro- and postbiotics may help treat hair loss.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Alopecia can lead to mental health issues, so treatment should address both skin and emotional health.

Trichohyalin may trigger the immune response causing alopecia areata.

Genetic differences affect COVID-19 severity and treatment development.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.